Form 4: Colgate-Palmolive Director Lisa Edwards Acquires Shares

Sentiment:

SEC Form 4 Filing


Director Lisa Edwards acquired 98 shares of Colgate-Palmolive common stock at $95.61 per share on July 1, 2024.

Summary

  • On July 1, 2024, Lisa Edwards, a director of Colgate-Palmolive, acquired 98 shares of common stock at a price of $95.61 per share.
  • This acquisition was part of a deferred compensation plan for non-employee directors.
  • Following the transaction, Edwards directly owns 13,918 shares of Colgate-Palmolive common stock.

Sentiment

Score: 6

Explanation: The sentiment is neutral. It's a routine transaction related to director compensation. The director's purchase could be seen as slightly positive, but it's not a significant market-moving event.

Positives

  • A director's acquisition of company stock can be seen as a positive signal, indicating confidence in the company's future performance.

Industry Context

Form 4 filings are routine disclosures required by the SEC when company insiders, such as directors and officers, trade their company's stock. These filings provide transparency into insider transactions and are closely watched by investors for signals about management's view of the company's prospects.

Stakeholder Impact

  • The transaction has a minimal direct impact on stakeholders.
  • It provides transparency to shareholders regarding insider trading activity.

Key Dates

DateDescription
07/01/2024Date of transaction: Lisa Edwards acquired 98 shares of Colgate-Palmolive common stock.
07/03/2024Date of signature: Kristine Hutchinson, Attorney-in-Fact, signed the Form 4 on behalf of Lisa Edwards.

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.